| Mark C Dillon, MD | |
|
1421 Malabar Rd Ne Ste 201, Palm Bay, FL 32907-2559 | |
| (321) 434-8423 | |
| (321) 434-8148 |
| Full Name | Mark C Dillon |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 37 Years |
| Location | 1421 Malabar Rd Ne Ste 201, Palm Bay, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013908920 | NPI | - | NPPES |
| 373405600 | Medicaid | FL | |
| 100013898 | Other | FL | RR MEDICARE |
| MM198 | Other | FL | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | ME63710 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Palm Bay Hospital | Palm bay, FL | Hospital |
| Holmes Regional Medical Center | Melbourne, FL | Hospital |
| Viera Hospital | Melbourne, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health First Medical Group Llc | 7416100672 | 713 |
News Archive
NPR explores the reasons for the high rates of HIV/AIDS infection among black women: "African-Americans, who only make up 1+2 percent of the U.S. population, account for nearly half of those living with HIV. More specifically, black women represent 61 percent of the new HIV cases among all women.
The Myelodysplastic Syndromes Group of Josep Carreras Leukaemia Research Institute, led by Dr. Francesc Solé, has participated in the first international study that confirms that having two mutated copies of the TP53 gene, as opposed to a single mutated copy, is associated with a worse prognosis in patients diagnosed with myelodysplastic syndrome (MDS).
Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.
Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them.
CSC announced today that the Centers for Medicare & Medicaid Services Office of Clinical Standards and Quality awarded the company a task order to migrate key information technology systems to a new service-oriented architecture. The contract, which was awarded during CSC's fiscal 2011 second quarter, has a six-month base period and six one-year options, bringing the estimated 78-month contract value to $230 million.
› Verified 1 days ago
| Entity Name | Health First Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626495 PECOS PAC ID: 7416100672 Enrollment ID: O20130122000135 |
News Archive
NPR explores the reasons for the high rates of HIV/AIDS infection among black women: "African-Americans, who only make up 1+2 percent of the U.S. population, account for nearly half of those living with HIV. More specifically, black women represent 61 percent of the new HIV cases among all women.
The Myelodysplastic Syndromes Group of Josep Carreras Leukaemia Research Institute, led by Dr. Francesc Solé, has participated in the first international study that confirms that having two mutated copies of the TP53 gene, as opposed to a single mutated copy, is associated with a worse prognosis in patients diagnosed with myelodysplastic syndrome (MDS).
Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.
Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them.
CSC announced today that the Centers for Medicare & Medicaid Services Office of Clinical Standards and Quality awarded the company a task order to migrate key information technology systems to a new service-oriented architecture. The contract, which was awarded during CSC's fiscal 2011 second quarter, has a six-month base period and six one-year options, bringing the estimated 78-month contract value to $230 million.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark C Dillon, MD 3300 S Fiske Blvd, Rockledge, FL 32955-4306 Ph: (321) 434-8423 | Mark C Dillon, MD 1421 Malabar Rd Ne Ste 201, Palm Bay, FL 32907-2559 Ph: (321) 434-8423 |
News Archive
NPR explores the reasons for the high rates of HIV/AIDS infection among black women: "African-Americans, who only make up 1+2 percent of the U.S. population, account for nearly half of those living with HIV. More specifically, black women represent 61 percent of the new HIV cases among all women.
The Myelodysplastic Syndromes Group of Josep Carreras Leukaemia Research Institute, led by Dr. Francesc Solé, has participated in the first international study that confirms that having two mutated copies of the TP53 gene, as opposed to a single mutated copy, is associated with a worse prognosis in patients diagnosed with myelodysplastic syndrome (MDS).
Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.
Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them.
CSC announced today that the Centers for Medicare & Medicaid Services Office of Clinical Standards and Quality awarded the company a task order to migrate key information technology systems to a new service-oriented architecture. The contract, which was awarded during CSC's fiscal 2011 second quarter, has a six-month base period and six one-year options, bringing the estimated 78-month contract value to $230 million.
› Verified 1 days ago
Dr. Francis Lamothe, MD PA Gastroenterology Medicare: Medicare Enrolled Practice Location: 5270 Babcock St Ne, Suite 1, Palm Bay, FL 32905 Phone: 321-722-5959 Fax: 321-722-5960 | |
Zafar Iqbal Sharar, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1421 Malabar Rd Ne, Suite 210, Palm Bay, FL 32907 Phone: 321-434-8140 Fax: 321-434-8143 | |
Leonard Grecul, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1421 Malabar Rd Ne Ste 201, Palm Bay, FL 32907 Phone: 321-434-8531 Fax: 321-434-8533 | |
Venkat Pavan Reddy Kancharla, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20 San Filippo Dr Se, Palm Bay, FL 32909 Phone: 321-725-8300 Fax: 321-725-1555 | |
Neil Kairsingh, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1810 Eldron Blvd Se, Palm Bay, FL 32909 Phone: 321-312-3466 Fax: 321-434-8143 | |
Gary Lee Robinson, D.O. Gastroenterology Medicare: Medicare Enrolled Practice Location: 5270 Babcock St Ne, Suite 1, Palm Bay, FL 32905 Phone: 321-722-5959 Fax: 321-722-5960 |